Videos

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses global and national initiatives for the development of new antibiotics.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, explains the economics of antimicrobial development.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, examines the threat that antibiotic resistance poses to modern medicine.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses the economic opportunities driving the development of new pharmaceuticals.

Barry Kreiswirth, PhD, founding director, Public Health Research Institute Tuberculosis Center, professor of medicine at Rutgers University, examines the difficulty of developing new, effective antibiotics as more and more bacteria continue to develop resistance.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how antibiotic stewardship programs are impacting antibiotic resistance.

Marcos Pires, PhD, assistant professor at Lehigh University, discusses future applications of immunotherapy.

Laura Cooley, MD, MPH medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, discusses the role water maintenance plays in the prevention of the spread of Legionnaires’ disease.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how public health institutions can work alongside private pharmaceutical companies to prevent antibiotic resistance.

Marcos Pires, PhD, assistant professor at Lehigh University, explains how augmenting the immune system's bacterial detection process can help fight infections.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses antibiotic stewardship programs in both the hospital and outpatient settings.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, explains what antibiotic stewardship is and what ideal antibiotic stewardship programs in hospitals look like.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, warns of the potential downsides to taking antibiotics.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, explains how antibiotics can be harmful if they are not used appropriately.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, compares antibiotic prescribing data in the United States to data in Europe.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how antibiotic prescribing data vary across the United States.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, talks about the importance of educating patients on antibiotic use.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses antibiotic prescribing data, with an emphasis on outpatient settings.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses “Get Smart About Antibiotics Week” and partnerships with international organizations.

Marcos Pires, PhD, assistant professor at Lehigh University, discusses the threat of antibiotic resistance.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, explains how his team identified national projections of drug-resistant pathogens.

Laura Cooley, MD, MPH, medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, explains why Legionella is such a challenging pathogen.

Jacob Morton, PharmD, MBA, BCPS, Antibiotic Stewardship Outcomes Post-Doctoral Research Fellow, Providence Veterans Affairs Medical Center, clinical pharmacy research specialist, explains that adult patients with comorbidities should be vaccinated for pneumococcal disease.

Laura Cooley, MD, MPH, medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, explains the current Legionella situation.

Jacob Morton, PharmD, MBA, BCPS, Antibiotic Stewardship Outcomes Post-Doctoral Research Fellow, Providence Veterans Affairs Medical Center, clinical pharmacy research specialist, Wesley Healthcare, discusses programs to improve pneumococcal vaccination rates in veterans.

Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, explains her recent research on influenza antiviral treatment prescribing practices in 60 outpatient settings across the United States.

Marcos Pires, PhD, assistant professor at Lehigh University, explains whether or not his team’s strategy to use immunotherapy as a substitute for antibiotics will vary from patient to patient.

Susan Kline, MD, MPH, associate professor of medicine, Division of Infectious Diseases and International Medicine, medical director for Infection Control, lead physician for Antibiotic Stewardship, University of Minnesota, discusses how restricting use of vancomycin impacted the emergence of vancomycin-resistant enterococci.

Megan Luther, PharmD, Advanced Health Services research fellow, Providence Veterans Affairs Medical Center, University of Rhode Island, College of Pharmacy, discusses a meta-analysis that examines the combination therapy of vancomycin and piperacillin/tazobactam causing acute kidney injuries.

Jacob Morton, PharmD, MBA, BCPS, Antibiotic Stewardship Outcomes Post-Doctoral Research Fellow, Providence Veterans Affairs Medical Center, clinical pharmacy research specialist, Wesley Healthcare, discusses his research on 30-day mortality in adults with pneumococcal disease.